Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Accel. buyback
Inv. presentation
Quarterly results
CC transcript
|
|
PFIZER INC (PFE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/10/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/29/2022 |
SC 13G
| PFIZER INC reports a 12% stake in ORIC PHARMACEUTICALS, INC. |
| 06/29/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/28/2022 |
SC 13G
| PFIZER INC reports a 6.7% stake in AKERO THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G
| PFIZER INC reports a 5.6% stake in eFFECTOR Therapeutics, Inc. |
| 02/11/2022 |
SC 13G
| PFIZER INC reports a 9.1% stake in Pyxis Oncology, Inc. |
| 11/19/2021 |
SC 13G
| PFIZER INC reports a 5.8% stake in Cardiff Oncology, Inc. |
| 09/20/2021 |
SC 13G
| PFIZER INC reports a 6.6% stake in ARVINAS, INC. |
| 07/09/2021 |
SC 13G
| PFIZER INC reports a 7.4% stake in Spero Therapeutics, Inc. |
| 02/12/2021 |
SC 13G
| PFIZER INC reports a 6.3% stake in 4D Molecular Therapeutics, Inc. |
| 02/12/2021 |
SC 13G
| PFIZER INC reports a 7% stake in BioAtla, Inc. |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/19/2020 |
SC 13G
| PFIZER INC reports a 9.9% stake in Homology Medicines, Inc. |
| 08/06/2020 |
SC 13G
| PFIZER INC reports a 6% stake in ESSA Pharma Inc. |
| 03/26/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G
| PFIZER INC reports a 8.3% stake in Morphic Holding, Inc. |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/16/2019 |
SC 13G
| PFIZER INC reports a 8.7% stake in ContraFect Corporation |
| 05/22/2019 |
SC 13G
| PFIZER INC reports a 12.2% stake in Cortexyme, Inc. |
| 05/22/2019 |
SC 13G
| PFIZER INC reports a 8.7% stake in NextCure, Inc. |
| 02/14/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/18/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/13/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2017 |
SC 13G
| PFIZER INC reports a 7.3% stake in Gemphire Therapeutics Inc. |
| 02/08/2017 |
SC 13G
| STATE STREET CORP reports a 5.3% stake in PFIZER INC. |
| 06/06/2016 |
SC 13G
| Merus B.V. reports a 7.1% stake in Merus N.V. |
| 05/12/2016 |
SC 13G
| Wave Life Sciences Ltd. reports a 8% stake in WAVE Life Sciences Ltd. |
| 03/09/2012 |
SC 13G
| Clovis Oncology, Inc. reports a 5.3% stake in CLOVIS ONCOLOGY, INC. |
| 01/29/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 08/28/2007 |
SC 13G
|
SEC Filing in the EDGAR database
|
| 06/22/2007 |
SC 13G
|
SEC Filing in the EDGAR database
|
|
|
|